Intercept Pharmaceuticals, Inc. (ICPT) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Intercept Pharmaceuticals, Inc., with annual and quarterly history.
| Metric | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | 3.63x | -3.58x | -2.51x | -10.03x | -9.28x | -4.06x |
| P/B Ratio | 4.49x | -2.82x | -4.88x | 76.08x | 149.97x | 89.32x |
| P/S Ratio | 1.46x | 1.43x | 2.60x | 15.57x | 15.96x | 11.18x |
| Profitability | ||||||
| Gross Margin | 99.7% | 99.1% | 98.3% | 98.3% | 98.6% | 99.0% |
| Operating Margin | -23.9% | -15.3% | -69.3% | -124.0% | -158.8% | -256.3% |
| Net Margin | 40.3% | -39.9% | -103.7% | -155.2% | -172.0% | -275.2% |
| EBITDA Margin | -21.6% | -9.6% | -67.9% | -116.9% | -155.0% | -252.8% |
| Liquidity | ||||||
| Current Ratio | 2.35x | 3.01x | 2.66x | 4.45x | 4.22x | 4.31x |
| Quick Ratio | 2.35x | 3.01x | 3.05x | 4.40x | 4.16x | 4.31x |
| Leverage | ||||||
| Debt/Equity | 3.57x | -2.97x | -3.45x | 10.45x | 19.41x | 21.71x |
YoY = year-over-year change. Source: FMP..